Filings (90d)
Other insiders active in the same sector
No other insider has filed at James Huang's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Huang?
James Huang is a corporate insider of Connect Biopharma Holdings Ltd (CNTB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James Huang last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 2 filings going back to 2026.
Has James Huang been buying or selling stock?
Recorded transactions: 2 open-market purchases ($4.37M) and 0 open-market sales across all tracked filings.
